top of page
Preventing cervical cancer in
EVERY CLINIC, EVERYWHERE
Anchor 1
Every 2 minutes, a woman dies of cervical cancer
Although cervical cancer is more than 90% preventable, and treatable
before it becomes malignant, 40+ million people with a cervix lack access to early prevention technologies each year
1-3
SCREENING
_edited.png)
A clinician can detect pre-cancerous cells through HPV DNA tests, Pap smears, VIA,
and other routine methods at a local clinic
6 - 10% of cervical screens are abnormal, meaning some sort of follow-up
treatment or care is required
4
.png)
_edited_edited.png)
GAPS IN CARE
50% of patients who screen positive never follow up, due to
at least one barrier
5
.png)
.png)
Current standard of care treatment methods rely on a broken supply chain of costly, bulky gas canisters that are difficult to transport, or they require specialists like OB/GYNs who are limited in number
BARRIERS TO
TREATMENT
6-7
ONSET OF CANCER
When pre-cancer cells are left untreated, they progress into
cervical cancer — meaning that instead of a simple intervention at a local clinic, a patient now faces surgery,
chemotherapy, or radiation
AT ANANYA HEALTH,
we are building tools to treat pre-cancerous cells at the point of diagnosis —
at any clinic, anywhere in the world
Screen
Treat
TM
Anchor 2
MEET CRCL
TM
A portable, easy-to-use, and highly effective cryoablation platform
that can be used in any clinic, anywhere, to prevent
abnormal cervical lesions from progressing into cancer
.png)
Closed loop system removes reliance on broken supply chain
Battery-powered with wheels for portability
Probe tip delivers 5mm depth of freeze
Our challenge is to ensure that...every woman over 30 is screened and treated for pre-cancerous lesions. To achieve that, we need innovative technologies and strategies.
Dr. Tedros Adhanom Ghebreyesus
WHO Director-General
EXPANDING ACCESS
to more clinics and more women
.png)
_edited.png){kind=small}
_edited.png){kind=small}
_edited.png){kind=small}
At 1/10th the cost of
gas-based traditional cryo system
_edited_edited.png)
No consumable cryogen means more predictable costs for patients and providers
.png)
More types of providers can provide effective treatment, overcoming the reliance on specialists
.png)
1/10th the cost per procedure of traditional
gas-based cryoablation
.png)
Proven, standard-of-care outcomes = fewer cases of cervical cancer
Anchor 3
Team
_JPG.jpg)
Advisors
_edited_edited_edited.jpg)
.png)
.png){kind=small}
Anchor 4
The latest from our Instagram feed
TM
Ananya Health 2023
Certain configurations of the CRCL System shown on this website are under development and not currently available in the United States. 1. WHO, 2020 2. CDC, 2020 3. Sung et al, GLOBOCAN, 2020 4. Eun et al, Screening for Cervical Cancer, 2020 5. Boitano et al, Increased disparities, 2022 6. Alfaro et al, Removing global barriers, 2021 7. WHO, 2012
bottom of page